Process for amplifying, detecting, and/or-cloning nucleic acid sequences
AssigneeCetus Corporation
InventorsKary B. Mullis, Henry A. Erlich, Norman Arnheim, Glenn T. Horn, Randall K. Saiki, Stephen J. Scharf
Life of this patent
Estimating the term…
Loading patent…
AssigneeCetus Corporation
InventorsKary B. Mullis, Henry A. Erlich, Norman Arnheim, Glenn T. Horn, Randall K. Saiki, Stephen J. Scharf
Estimating the term…
The present invention is directed to a process for amplifying and detecting any target nucleic acid sequence contained in a nucleic acid or mixture thereof. The process comprises treating separate complementary strands of the nucleic acid with a molar excess of two oligonucleotide primers, extending the primers to form complementary primer extension products which act as templates for synthesizing the desired nucleic acid sequence, and detecting the sequence so amplified. The steps of the reaction may be carried out stepwise or simultaneously and can be repeated as often as desired. In addition, a specific nucleic acid sequence may be cloned into a vector by using primers to amplify the sequence, which contain restriction sites on their non-complementary ends, and a nucleic acid fragment may be prepared from an existing shorter fragment using the amplification process.
A process for detecting the presence or absence of at least one specific nuclei acid sequence in a sample containing a nucleic acid or mixture of nucleic acids, or distinguishing between two different sequences in said sample, wherein the sample is suspected of containing said sequence or sequences, which process comprises:
A process for detecting the presence or absence of a nucleic acid sequence containing a polymorphic restriction site specific for sickle cell anemia which sequence is suspected of being contained in a sample, which process comprises:
A process for synthesizing a nucleic acid fragment from an existing nucleic acid fragment having fewer nucleotides than the fragment being synthesized and two oligonucleotide primers, wherein the nucleic acid being synthesized is comprised of a left segment, a core segment and a right segment, and wherein the core segment is sufficiently complementary to the nucleotide sequence of said existing nucleic acid fragment to hybridize therewith, and the right and left segments represent the nucleotide sequence present in the 5' ends of the two primers, the 3' ends of which are complementary to, or sufficiently complementary to hybridize with, the 3' ends of the single strands produced by separating the strands of said existing nucleic acid fragment, which process comprises:
A process for cloning into bacteriophage M13 a polymorphic genetic sequence on the human HLA DQ, DR or DP Class Ii .alpha. and .beta. genes, which process comprises:
Dependencies are inferred from the claim text.